Sreeja Biswas covers funding and M&A in the healthcare sector during weekdays. On weekends, she indulges in long-form writing and explores the best culinary spots in town.
Healthcare
Searchlight: Datt Mediproducts hits mild bump in revenue but EBITDA looking upbeat
Healthcare supplies manufacturer Datt Mediproducts Pvt. Ltd. reported a marginal dip in revenue for the fiscal year ......
Healthcare
OTPP-backed Sahyadri Hospitals draws interest from PE firms, strategic suitors
A number of global private equity firms and homegrown strategic suitors have lined up to bid for Sahyadri Hospitals, ......
Healthcare
360 One Asset's Tarun Sharma on investment thesis, sweet spots in Indian healthcare and more
Private equity giant Bain Capital-backed asset manager 360 One Asset is currently underway raising capital for its ......
Manufacturing
PremjiInvest eyes controlling stake in packaging firm
PremjiInvest, the family office of Wipro founder chairman Azim Premji, has joined the race to acquire a majority stake ......
General
Grapevine: Haldiram, Alpha Wave Global, Jar, Prosus, GIC, and BharatPe in news
Alpha Wave Global has joined the race for a minority stake in Haldiram Snacks Food, while Prosus is in advanced ......
Manufacturing
How did ICICI Venture perform in exit from eight-year-old bet?
ICICI Venture, the private equity arm of ICICI Bank, has continued its harvest spree, as it logs out of its ......
Healthcare
Metropolis Healthcare to acquire Core Diagnostics for $29 mn
Metropolis Healthcare Ltd, India’s second-largest pathology chain, said Monday it will acquire oncology-focused ......
Healthcare
Somerset bets on medical devices maker in maiden deal from third fund
Healthcare-focused Indian private equity firm Somerset Indus Capital Partners, which is an investor in companies such as......
General
Grapevine: Flipkart, Switz Group, Theobroma, Apna Mart, and Amazon India in news
Flipkart plans to go public within 12-15 months and Switz Group has partnered with Singapore's GIC to bet for ......
Healthcare
Advent-owned Suven Pharma to buy majority stake in NJ Bio for $64 mn
Private equity giant Advent International-owned contract development and manufacturing organization (CDMO) Suven Pharma ......















